NASDAQ:NKGN

Nkgen Biotech Stock Forecast

etoro logo Buy NKGN
*Your capital is at risk
$0.0600
+0 (+0%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of NKGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NKGN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Wednesday for NKGen Biotech, Inc. stock after losing 0%
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 28, 2026

No changes to the price of NKGen Biotech, Inc. stock on the last trading day (Wednesday, 3rd Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0600 to a day high of $0.0600. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.13% during the next 3 months and, with a 90% probability hold a price between $0.0299 and $0.132 at the end of this 3-month period.

NKGN Signals & Forecast

There are few to no technical positive signals at the moment. The NKGen Biotech, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0600 and $0.0636. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 08, 2026, and so far it has fallen -62.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NKGen Biotech, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NKGN) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect NKGen Biotech, Inc. to open at $0.0600, and during the day (based on 14 day Average True Range), to move between $0.0570 and $0.0630, which gives a possible trading interval of +/-$0.0060 (+/-10.52%) up or down from last closing price. If NKGen Biotech, Inc. takes out the full calculated possible swing range there will be an estimated 10.52% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0700, some $0.0100 (16.67%) from the current price of $0.0600, our system finds the risk reward not very attractive.

Is NKGen Biotech, Inc. stock A Buy?

NKGen Biotech, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.042 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $0.0600 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NKGN Performance

Trading levels for NKGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0600 -
R2 0.0600 -
R1 0.0600 -
Price 0.0600
S1 0.0600 -
S2 0.0600 -
S3 0.0600 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0.0700 16.67%
Price 0.0600
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for NKGen Biotech, Inc. Stock and on which exchange is it traded?
The symbol for NKGen Biotech, Inc. is NKGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NKGen Biotech, Inc. Stock?
NKGen Biotech, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy NKGen Biotech, Inc. Stock?
NKGen Biotech, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NKGen Biotech, Inc. Stock.

What's the current price of NKGen Biotech, Inc. Stock?
As of the end of day on the Jun 03, 2026, the price of an NKGen Biotech, Inc. (NKGN) share was $0.0600.

What is the 52-week high and low for NKGen Biotech, Inc. Stock?
The 52-week high for NKGen Biotech, Inc. Stock is $0.450 and the 52-week low is $0.0003.

What is the market capitalization of NKGen Biotech, Inc. Stock?
As of the Jun 03, 2026, the market capitalization of NKGen Biotech, Inc. is 7.836M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE